In conclusion, DDX49 was a novel predictor for diagnosing lymph node metastases of lung cancer; thus, the marker can be used to improve or even replace enhanced CT for the diagnosis of lymph node metastases. This evidence concerns the gene DDX49 and lung carcinoma.